CPHI Japan 2011

Japan’s pharmaceutical industry is a pro-innovative marketplace with total sales expected to rise to $80 billion by 2012. The regulatory barriers that traditionally shaped the Japanese pharmaceutical market over the last 10 years have started to come down; as a result the future offers major growth prospects for pharmaceutical businesses. The opening up of the generic market, strongly supported by the government, patent expiries and the largely un-penetrated nature of the market are all contributing factors towards its growth.

Exhibiting at CPhI Japan is a great opportunity to:
• Showcase your latest products and innovations on a cost-effective way
• Meet 14,000 senior decision makers from Japan and overseas
• Recruit new customers and strengthen relationships with current clients
• Benefit from new pharmaceutical laws that make business opportunities for international companies easier